Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population.

Methylenetetrahydrofolate reductase (MTHFR) plays a centralrole in converting folate to methyl donor for DNA methylation, an epigenetic modification known to be dysregulated in carcinogenesis. Our previous study revealed that MTHFR polymorphisms contribute to a great risk of esophageal cancer in a Chinese population. This case-control study was to examine the association between MTHFR polymorphisms and gastric cardia adenocarcinoma (GCA), which is also prevalent in high-risk areas of esophageal cancer and thus may share common etiological factors with esophageal cancer in this population. The study subjects were 217 patients with GCA and 468 population controls matched on sex and age. The MTHFR C677T and A1298C genotypes were detected by a PCR-based RFLP assay. It was found that subjects with the MTHFR 677TT variant genotype had a 2-fold increased risk of GCA (odds ratio, 2.04; 95% confidence interval, 1.28-3.26). Moreover, a significantly elevated risk was also seen among the MTHFR 677CT heterozygotes (odds ratio, 1.56; 95% confidence interval, 1.03-2.36). The MTHFR A1298C polymorphism had no effect on risk of GCA. These findings are generally consistent with our initial observation for esophageal cancer and suggest that the MTHFR genotype may be a determinant of GCA among this at-risk Chinese population.

[1]  C. J. Roberts,et al.  Abnormal chromosome behavior in Neurospora mutants defective in DNA methylation , 1995, Science.

[2]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[3]  S. Bianchi,et al.  A case-control study of cancers of the gastric cardia in Italy. , 1992, British Journal of Cancer.

[4]  A. Ronnenberg,et al.  Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age. , 2000, The Journal of nutrition.

[5]  S. Duthie,et al.  Folic acid deficiency and cancer: mechanisms of DNA instability. , 1999, British medical bulletin.

[6]  L. Glória,et al.  Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. , 1996, Gut.

[7]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[8]  J. Mason,et al.  Folate and carcinogenesis: an integrated scheme. , 2000, The Journal of nutrition.

[9]  G. M. Taylor,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Ames,et al.  Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. , 2001, Carcinogenesis.

[11]  S. Wacholder,et al.  A case‐control study of cancer of the esophagus and gastric cardia in linxian , 1989, International journal of cancer.

[12]  C. Wagner.  BIOCHEMICAL ROLE OF FOLATE IN CELLULAR METABOLISM* , 2001 .

[13]  Q. Wei,et al.  Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. , 2001, Cancer research.

[14]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[15]  D. Heimburger,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. , 2000, Anticancer research.

[16]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[17]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[18]  R. Gershoni-baruch,et al.  Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. , 2000, European journal of cancer.

[19]  X. Zhou,et al.  Alterations of level of total genomic DNA methylation and pattern of c-myc, c-Ha-ras oncogene methylation in human gastric carcinogenesis. , 1996, Chinese medical journal.

[20]  Hongbing Shen,et al.  Polymorphisms of 5,10‐methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case‐control study , 2001, International journal of cancer.

[21]  Jinfu Hu,et al.  Risk factors for oesophageal cancer in northeast China , 1994, International journal of cancer.

[22]  Zuo-Feng Zhang,et al.  Adenocarcinomas of the esophagus and gastric cardia: the role of diet. , 1997, Nutrition and cancer.

[23]  C. S. Yang,et al.  Nutritional status in Linxian, China: effects of season and supplementation. , 1989, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[24]  P. Taylor,et al.  A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. , 1994, International journal of epidemiology.

[25]  A. Wolk,et al.  Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  D. Girelli,et al.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Mason,et al.  Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  G. Morgan,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Quilliot,et al.  The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. , 2000, The British journal of nutrition.

[30]  J. Chang-Claude,et al.  An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Huixian, China. , 1990, Cancer research.

[31]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[32]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.

[33]  J. Mason,et al.  The effect of dietary folate on Apc and p53 mutations in the dimethylhydrazine rat model of colorectal cancer. , 1999, Carcinogenesis.

[34]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[35]  S. Xiao,et al.  Studies on the hypomethylation of c‐myc, c‐Ha‐ras oncogenes and histopathological changes in human gastric carcinoma , 1996, Journal of gastroenterology and hepatology.

[36]  M. Esteller,et al.  Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. , 1997, Carcinogenesis.